Apex, NC, United States of America

Jeffrey David Yingling

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey David Yingling

Introduction: Jeffrey David Yingling, based in Apex, North Carolina, is a noteworthy inventor with a portfolio that includes two significant patents. His work is primarily focused on the development of pharmaceutical compounds that address critical health conditions.

Latest Patents: Yingling's recent patents include innovations in isoquinoline compounds. These compounds have been designed to influence, inhibit, or reduce the action of a G-protein receptor kinase. The patent also covers pharmaceutical compositions that incorporate therapeutically effective amounts of these isoquinoline compounds alongside suitable pharmaceutical carriers. Furthermore, his research delineates various methods utilizing these compounds to combat disease states such as cancer, osteoporosis, and glaucoma. Another notable patent pertains to methods for determining phosphoryltransferase activity using adenosine 5'-triphosphate (ATP)-gamma-S. This invention introduces screening assay methods applicable to a wide array of protein kinase genes, proving invaluable in the detection and evaluation of kinase inhibitors.

Career Highlights: Throughout his career, Yingling has made significant contributions to the field of pharmaceuticals, particularly in drug development. He has held vital roles in prominent companies, including Aerie Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, where he applied his expertise in drug innovation.

Collaborations: Yingling has collaborated with esteemed colleagues, such as Mitchell Anthony deLong and Marcos Sznaidman. These partnerships have further enriched his research and broadened the impact of his inventions in the pharmaceutical landscape.

Conclusion: Jeffrey David Yingling's innovative work, particularly in isoquinoline compounds and kinase activity assays, signifies his crucial role in advancing pharmaceutical solutions for serious health issues. His dedication and expertise continue to influence drug development and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…